IMR Press / CEOG / Volume 24 / Issue 2 / pii/1997015

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

An eight year review of hospitalization for ovarian hyperstimulation syndrome

Show Less
1 Division of Reproductive Endocrinology/lnfertility Department of Obstetrics, Gynecology, and Reproductive Sciences, UMDNJ-Robert Wood Johnson Medical School; New Brunswick New Jersey (USA)
Clin. Exp. Obstet. Gynecol. 1997, 24(2), 49–52;
Published: 10 June 1997
Abstract

We analyzed the etiologic factors and trends of hospitalization for ovarian hospitalization syndrome (OHSS) resulting from the use of fertility medications. From May, 1986 through April, 1994, patients hospitalized with OHSS were exclusively admitted to the Uni­versity Hospital. Analysis was performed with regards to treatment method, severity of hyperstimulation, and onset of disease. Overail, 14 patients were hospitalized for a rate per cycle of 0.1 % (14/14, 283). The rate of admission for patients undergoing superovu­lation (9/12, 945;.07%) was significantly lower than for those undergoing assisted reproductive techniques (ART) (5/1, 338;.37%). The total number of injectable gonadotropin ampules used was also higher in patients admitted following ART versus superovulation. A significantly greater number of patients presenting with late developing hyperstimulation syndrome (5/7; 71.4%) manifested seve­re disease as opposed to those hospitalized with early onset OHSS (1/7; 14.3%). Our data suggest that hospital admission is an infrequent event following the use of fertility medications, and patients are more likely to be hospitalized with OHSS following ART than superovulation.

Keywords
Hospitalization
Ovarian hyperstimulation syndrome
Share
Back to top